Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
about
Recurrent venous thromboembolism: what is the risk and how to prevent itManaging pulmonary embolism using prognostic models: future concepts for primary carePredicting the risk of venous thromboembolism recurrenceThe epidemiology of venous thromboembolismDuration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysisOptimal duration of anticoagulation in patients with venous thromboembolism.Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approachVenous thrombosis: understanding the paradoxes of recurrence.Thrombosis in women: what are the knowledge gaps in 2013?Thrombophilia: clinical-practical aspects.Recurrence risk of venous thromboembolism and hormone use in women from England: a cohort study using clinical practice research datalink.Retrospective evaluation of venous thromboembolism: Are all transient provoking events the same?Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study.Epidemiology of venous thromboembolism.The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism.
P2860
Q26826847-01B3D551-6017-4641-8273-DACFCE21D3BAQ26830769-F977978E-4232-4EAD-814B-ACCF8A99D996Q26865059-57FC1648-CEA9-43E3-8EC2-2A3D4EB3C433Q28067893-1638A5B4-801F-478F-ADDC-0A2A9F1B54B0Q34284224-0988395F-62A8-4F4F-B09C-5D25B6B8CA89Q34603112-A06D2C23-D79C-417C-975C-8E4619A915D1Q35210139-D82A2CCE-43BC-4C2F-9AD8-DF3A86799D0BQ36718482-32BAA6EF-E262-471C-AADF-05072D1C5666Q38117733-8845092B-802C-4631-AF8C-30D01F6F7037Q38117735-B31D9730-7686-41FB-BE76-CEFBDAEE906BQ38365992-C7CB18F0-A88D-4435-BCE1-DDADEEFE1EE0Q38851530-004C693A-A1DB-47BD-B436-59A50AB57621Q40286754-AE3A4DBE-AC49-495F-B139-54732263956CQ40928535-06106372-49E0-48C0-A6D6-1965B993A2A8Q41667853-793BE411-6078-47FA-9973-9EB6737E04C7Q51515902-49BCF14E-7125-4894-AC32-53497A11EA7C
P2860
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk of recurrent venous throm ...... from the REVERSE cohort study.
@ast
Risk of recurrent venous throm ...... from the REVERSE cohort study.
@en
type
label
Risk of recurrent venous throm ...... from the REVERSE cohort study.
@ast
Risk of recurrent venous throm ...... from the REVERSE cohort study.
@en
prefLabel
Risk of recurrent venous throm ...... from the REVERSE cohort study.
@ast
Risk of recurrent venous throm ...... from the REVERSE cohort study.
@en
P2093
P356
P1476
Risk of recurrent venous throm ...... from the REVERSE cohort study.
@en
P2093
David A Anderson
Grégoire Le Gal
Isabelle Chagnon
Karine Lacut
Kimberley Do
Linda Vickars
Marc Righini
Marc Rodger
Mark Crowther
Michael J Kovacs
P304
P356
10.1160/TH09-10-0685
P50
P577
2010-06-10T00:00:00Z